JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1998) 159, 239-246       DOI: 10.1677/joe.0.1590239
© 1998 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (33)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soto, L
Right arrow Articles by Lopez-Calderon, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soto, L
Right arrow Articles by Lopez-Calderon, A
Journal of Endocrinology, Vol 159, Issue 2, 239-246
Copyright © 1998 by Society for Endocrinology


Articles

Effects of endotoxin lipopolysaccharide administration on the somatotropic axis

L Soto, AI Martin, S Millan, E Vara, and A Lopez-Calderon


The aim of this work was to study the effect of chronic activation of the immune system on the somatotropic axis. Accordingly, the changes in growth hormone (GH) secretion, circulating insulin-like growth factor-I (IGF-I) and IGF binding proteins (IGFBPs) in response to endotoxin lipopolysaccharide (LPS) administration were examined in adult male Wistar rats. Acute LPS injection (2.5, 25 or 250 microg/kg) increased serum corticosterone in a dose-dependent manner and decreased serum levels of insulin and IGF-I, serum GH concentration declined linearly as the LPS dose increased. Western ligand blot showed an increase in the 33 kDa band (corresponding to IGFBP-1 and IGFBP-2) in the rats that received the highest dose of LPS (250 microg/kg). Chronic LPS administration (250 microg/kg daily for 8 days) significantly decreased body weight, serum levels of IGF-I and pituitary GH content, whereas it increased circulating IGFBP-3 (47 kDa band), IGFBP-1 and IGFBP-2 (33 kDa band) and the 24 kDa band (which possibly corresponds to IGFBP-4). Serum concentration of corticosterone and hypothalamic somatostatin content were also increased by chronic LPS treatment. These data suggest that the decrease in GH and IGF-I secretion and the increase in circulating IGFBPs are important mechanisms in body weight loss during chronic inflammation.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Granado, A. I. Martin, M. Lopez-Menduina, A. Lopez-Calderon, and M. A. Villanua
GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E131 - E141.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
C.-L. Huang, P.-S. Tsai, T.-Y. Wang, L.-P. Yan, H.-Z. Xu, and C.-J. Huang
Acupuncture Stimulation of ST36 (Zusanli) Attenuates Acute Renal but Not Hepatic Injury in Lipopolysaccharide-Stimulated Rats
Anesth. Analg., March 1, 2007; 104(3): 646 - 654.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
L. Wang, N. R. Basa, A. Shaikh, A. Luckey, D. Heber, D. H. St-Pierre, and Y. Tache
LPS inhibits fasted plasma ghrelin levels in rats: role of IL-1 and PGs and functional implications.
Am J Physiol Gastrointest Liver Physiol, October 1, 2006; 291(4): G611 - G620.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T. Priego, M. Granado, E. Castillero, A. I. Martin, M A. Villanua, and A. Lopez-Calderon
Nitric oxide production by hepatocytes contributes to the inhibitory effect of endotoxin on insulin-like growth factor I gene expression.
J. Endocrinol., September 1, 2006; 190(3): 847 - 856.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
M Granado, A I Martin, T Priego, M A Villanua, and A Lopez-Calderon
Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression.
J. Endocrinol., March 1, 2006; 188(3): 503 - 511.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
X. F. Mao, X. S. Piao, C. H. Lai, D. F. Li, J. J. Xing, and B. L. Shi
Effects of {beta}-glucan obtained from the Chinese herb Astragalus membranaceus and lipopolysaccharide challenge on performance, immunological, adrenal, and somatotropic responses of weanling pigs
J Anim Sci, December 1, 2005; 83(12): 2775 - 2782.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
T. Priego, M. Granado, A. I. Martin, A. Lopez-Calderon, and M. A. Villanua
Dexamethasone administration attenuates the inhibitory effect of lipopolysaccharide on IGF-I and IGF-binding protein-3 in adult rats
J. Endocrinol., June 1, 2005; 185(3): 467 - 476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Priego, I. Ibanez de Caceres, A. I. Martin, M. A. Villanua, and A. Lopez-Calderon
NO plays a role in LPS-induced decreases in circulating IGF-I and IGFBP-3 and their gene expression in the liver
Am J Physiol Endocrinol Metab, January 1, 2004; 286(1): E50 - E56.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Hataya, T. Akamizu, H. Hosoda, N. Kanamoto, K. Moriyama, K. Kangawa, K. Takaya, and K. Nakao
Alterations of Plasma Ghrelin Levels in Rats with Lipopolysaccharide-Induced Wasting Syndrome and Effects of Ghrelin Treatment on the Syndrome
Endocrinology, December 1, 2003; 144(12): 5365 - 5371.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
Y. L. Liu, D. F. Li, L. M. Gong, G. F. Yi, A. M. Gaines, and J. A. Carroll
Effects of fish oil supplementation on the performance and the immunological, adrenal, and somatotropic responses of weaned pigs after an Escherichia coli lipopolysaccharide challenge
J Anim Sci, November 1, 2003; 81(11): 2758 - 2765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S.-E. Kong, S. M. Firth, R. C. Baxter, and P. J. D. Delhanty
Regulation of the acid-labile subunit in sustained endotoxemia
Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E692 - E701.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Fernandez-Celemin and J.-P. Thissen
Interleukin-6 Stimulates Hepatic Insulin-Like Growth Factor Binding Protein-4 Messenger Ribonucleic Acid and Protein
Endocrinology, January 1, 2001; 142(1): 241 - 248.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. Raina, J. Matsui, and K. N Jeejeebhoy
Nutritional and metabolic effects of the endotoxin bacterial lipopolysaccharide in orally and parenterally fed rats
Am. J. Clinical Nutrition, March 1, 2000; 71(3): 835 - 843.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the Society for Endocrinology.